Jazz Pharmaceuticals

ISIN IE00B4Q5ZN47

WKN A1JS1K

Marktkapitalisatie (in EUR)

13.818 m

Land

Ierland

Sector

Gezondheidszorg

Dividendrendement

0,00%

Overzicht

Koers

Beschrijving

Jazz Pharmaceuticals Plc is een biofarmaceutisch bedrijf dat zich richt op de identificatie, ontwikkeling en commercialisering van farmaceutische producten op het gebied van narcolepsie, oncologie, pijn en psychiatrie. De productportefeuille omvat: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos en Defitelio. Het bedrijf werd in maart 2003 opgericht door Bruce C. Cozadd en het hoofdkantoor is gevestigd in Dublin, Ierland.

Toon meer Toon minder

Gezondheidszorg Biofarmaceutica SysteemspecifiekeÂ Biofarmaceutica Ierland

Grafiek

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR	13.818 m
WPA, EUR	12,43
KBV	3,4
K/W	17,2
Dividendrendement	0,00%

Winst- en verliesrekening (2025)

Omzet, EUR	3.783 m
Netto-inkomen, EUR	-316 m
Winstmarge	-8,35%

In welke ETF zit Jazz Pharmaceuticals?

Er zijn 7 ETF's die Jazz Pharmaceuticals bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van Jazz Pharmaceuticals is de iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weging	Investeringsfocus	Fondsgrootte (in m EUR)
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	1,06%	Aandelen Verenigde Staten Gezondheidszorg Biotech	72
Vanguard Russell 1000 U.S. Value UCITS ETF USD Dist	0,04%	Aandelen Verenigde Staten Waarde	2
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0,02%	Aandelen Wereld Sociaal/Milieu	596
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0,02%	Aandelen Noord-Amerika Sociaal/Milieu	27
Vanguard Russell U.S. Mid-Cap UCITS ETF USD Dist	0,10%	Aandelen Verenigde Staten Mid Cap	3
JPMorgan Global Equity Active UCITS ETF USD (dist)	0,50%	Aandelen Wereld Sociaal/Milieu	1
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0,20%	Aandelen Verenigde Staten Small Cap	231

Prestaties

Rendementsoverzicht

YTD	+51,27%
1 maand	-2,22%
3 maanden	+5,69%
6 maanden	+48,47%
1 jaar	+107,80%
3 jaar	+69,43%
5 jaar	+87,87%
Since inception	+122,86%
2025	+23,85%
2024	+4,51%
2023	-24,44%
2022	+27,06%

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).